Exalys Therapeutics is developing a portfolio of novel anti-inflammatory therapeutics with best-in-class properties to target a range of diseases with urgent unmet needs and limited treatment options.

Biotechnology

Education

Exalys Therapeutics

Rick Orr

Shashidhar Kori

Lynne Rollins

William Martin

Julien Mamet

The executive team at Exalys Therapeutics has experience working in finance, healthcare, and consulting. They have a variety of educational backgrounds including finance, business administration, management, and engineering. They have worked at companies such as Rollins Consulting, Baxter Healthcare, NewBio, Adynxx, WKM Consulting, LLC, and Corthera.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Exalys Therapeutics

Board of Directors

Leadership Team